Fox Chase Cancer Center Chooses Progenesis

Fox Chase Cancer Center Chooses Progenesis from Nonlinear Dynamics for Proteomics Research

(Newcastle upon Tyne, UK and Philadelphia, PA) Nonlinear Dynamics Ltd, a leading provider of bioinformatics solutions, announced that Fox Chase Cancer Center has chosen Progenesis as the automated solution for its proteomics research.The leading cancer research facility uses 2D gel electrophoresis technology for its protein studies, and generating reliable data from these 2D gels is crucial to the success of any project. Progenesis provides a totally new concept in automation. It is a unique, scalable solution that tackles the well-documented problems associated with 2D gel electrophoresis analysis, giving fast, accurate and reproducible results.

Steven Seeholzer, staff scientist at Fox Chase Cancer Center, said, "The analysis stage of 2D electrophoresis has always represented a major bottleneck in proteomic research. We have evaluated various options to overcome these issues and as a result first purchased Phoretix 2D Advanced, until now the clear leader in 2D gel analysis. But now we have recognised the clear advantage of Progenesis." He added, "This new product enables us to achieve new levels of throughput, providing a level of reliability and accuracy and objectivity we have never before seen."

Bob Marchmont, president of Nonlinear USA Inc., said, "We are delighted that such a well-respected cancer center as Fox Chase has become a Progenesis customer. Progenesis truly represents a breakthrough in 2D gel analysis, changing the landscape of proteomic possibilities. We are looking forward to working with Fox Chase to help to realise this potential within the Center's research." He added, "Close collaboration with our customers is paramount to us. We are continuing to invest heavily in our US subsidiary in order to provide the highest quality of support to our customers throughout the United States."

About Fox Chase Cancer Center

Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach.

About Nonlinear Dynamics Ltd

Established in 1989, Nonlinear Dynamics is a leading worldwide provider of bioinformatics solutions to the life science industry. The Company's innovative product portfolio comprises high-quality analysis and data mining tools for 1D and 2D electrophoresis gels and microarrays, the core technologies of genomics and proteomics. Nonlinear sells and supports its products through its UK headquarters, its USA office, and its global network of partners and OEMs.

Contact us for more information, or contact our Marketing Department directly.
Released: 16 August 2001

Current press releases | Archive press releases